June 2026
The global U.S. regenerative medicine market size was evaluated at USD 19.77 billion in 2025 and is predicted to hit around USD 102.23 billion by 2035, growing at a CAGR of 17.86%.
April 2026
The U.S. concierge medicine market size is valued at USD 6.55 billion in 2025 and is projected to be worth around USD 12.75 billion by 2035 with CAGR of 6.88%.
March 2026
The regenerative medicine market size is valued at USD 43.77 billion in 2025 and is expected to hit around USD 234.85 billion by 2035, growing at a CAGR of 18.29%.
October 2025
The global regenerative medicine in dermatology market is poised to grow as advanced cell-based and biomaterial therapies revolutionize skin repair and restoration.
June 2025
The U.S. precision medicine market size surpassed USD 49.79 billion in 2024 and is predicted to reach around USD 232.49 billion by 2034 with a solid CAGR of 16.66%.
September 2025
The global autologous stem cell and non-stem cell based therapies market size is estimated to hit around USD 25.78 billion by 2034 increasing from USD 8.64 billion in 2024, with a CAGR of 11.55%.
August 2025
The global fibroblast growth factors (FGFs) market size is estimated to hit around USD 8.03 billion by 2034 increasing from USD 3.54 billion in 2024, with a CAGR of 8.54%.
June 2026
The U.S. clinical trial supply and logistics market size was evaluated at USD 1.54 billion in 2025 and is predicted to hit around USD 3.13 billion by 2035, growing at a CAGR of 7.35%.
June 2026
The U.S. cell therapy manufacturing market size was evaluated at USD 1.71 billion in 2025 and is predicted to hit around USD 6.56 billion by 2035, growing at a CAGR of 14.39%.
June 2026
The U.S. health and wellness market size was evaluated at USD 2.31 trillion in 2025 and is predicted to surpass around USD 3.90 trillion by 2035, growing at a CAGR of 5.38%.
June 2026
The U.S. systemic inflammatory response syndrome treatment market size was evaluated at USD 4.88 billion in 2025 and is predicted to hit around USD 8.83 billion by 2035, growing at a CAGR of 6.11%.
June 2026
The U.S. perfusion system market size was evaluated at USD 6,78,407.71 thousand in 2025 and is predicted to hit around USD 16,24,531.09 thousand by 2035, growing at a CAGR of 9.20%.
June 2026
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
June 2026
The U.S. endoscopes market size surpassed USD 5.19 billion in 2025 and is predicted to reach around USD 12.09 billion by 2035, at a notable CAGR of 8.82%.
June 2026
The U.S. blood pressure monitoring devices market size is projected to surpass around USD 1,476.66 million by 2035 from USD 721.30 million in 2025, with a notable CAGR of 7.43%.
June 2026
The U.S. brain computer interface market size is valued at USD 617.60 million in 2025 and is projected to hit around USD 3,057.40 million by 2035 with a CAGR of 17.34%.
June 2026
The U.S. generic sterile injectable market size was evaluated at USD 17.91 billion in 2025 and is predicted to hit around USD 43.26 billion by 2035, growing at a CAGR of 9.22%.
June 2026
The U.S. healthcare consumables market size is estimated at USD 47.94 billion in 2025 and is projected to hit around USD 63.66 billion by 2035 with a CAGR of 2.88%.
June 2026
The U.S. non-invasive aesthetic treatment market size is projected to hit around USD 16.43 billion by 2035, from USD 8.03 billion in 2025, with a notable CAGR of 7.42%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
June 2026
The U.S. viral vectors and plasmid DNA manufacturing market size was evaluated at USD 2.84 billion in 2025 and is predicted to hit around USD 11.69 billion by 2035, growing at a CAGR of 15.20%.
June 2026
The U.S. insulin pump market size was evaluated at USD 2.29 billion in 2025 and is predicted to hit around USD 5.13 billion by 2035, growing at a CAGR of 8.40%.
June 2026
The U.S. retail clinics market size reached USD 4.18Â billion in 2025 and is projected to hit around USD 9.05 billion by 2035, growing at a notable CAGR of 8.03%.
May 2026
The U.S. pharmacy benefit management market size is expected to hit around USD 1,120.83 billion by 2035 from USD 459.65 billion in 2025, with a CAGR of 9.32%.
May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The U.S. revenue cycle management market size was valued at USD 65.43 billion in 2025 and is predicted to hit around USD 191.67 billion by 2035, at a CAGR of 11.50%.
May 2026
The U.S. complex and chronic condition management market size is valued at USD 7.47 billion in 2026 and is expected to reach over USD 18.33 billion by 2035, with a registered CAGR of 11.18%.
May 2026
The U.S. compounding pharmacies market size is valued at USD 6.45 billion in 2025 and is expected to hit around USD 11.52 billion by 2035, growing at a CAGR of 5.97%.
May 2026
The global U.S. oral care market size is calculated at USD 10.62 billion in 2025 and is projected to hit around USD 16.60 billion by 2035 with a CAGR of 4.57%.
May 2026
The U.S. fertility market size was evaluated at USD 9 billion in 2025 and is predicted to surpass around USD 21.36 billion by 2035, growing at a CAGR of 9.03%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com